Inanovate is a brand that aims to open doors to a smaller world by providing advanced technology and solutions in the field of protein screening and diagnostics. Their flagship product, the Bio-ID, is a compact bench-top analyzer that combines cutting-edge Bio-ID technology with disposable test cartridges. This technology allows for the rapid and precise measurement of multiple disease-related biological molecules (biomarkers) in patient blood samples.

Inanovate focuses on addressing critical needs in breast cancer diagnosis and monitoring. They have developed tests that combine the Bio-ID platform with patent-protected breast cancer specific biomarkers. In clinical trials, these biomarkers have demonstrated the capability to identify breast cancer with a sensitivity of 83% and a specificity of 70%.

If confirmed through extended trials, this test has the potential to save tens of thousands of lives each year and improve the quality of life for millions more. With their revolutionary technology and commitment to advancing the life sciences industry, Inanovate is dedicated to providing the world's leading technology for screening and analyzing proteins